Health
Retatrutide: The Triple Agonist Still Proving Itself
Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026
Loading
Search
Results
21 stories for“class of 2026”
Health
Qatar's New Scholarship Program Prepares Students for Life Beyond the Lecture Hall
The Zad Al-Mubta'ath program will combine academic advice with mental health, financial literacy, cultural guidance and digital security.
Jul 30, 2026
Health
The WHO Has Put Fungal Infections on the Danger List
New guidance targets a threat the agency calls one of the most neglected in global health. The problem is not just the infections, it is how few drugs exist to treat them.
Aug 4, 2026
